The Emory MSTP prepares highly gifted and motivated students to pursue careers as physician-scientists and leaders in biomedical research. The seven to eight year training process leads to both M.D. and Ph.D. degrees. The M.D./Ph.D. Executive Committee, comprised of institutional leadership representing the many academic units involved in training, is responsible for oversight of the program. Selection of applicants is highly competitive and is made by the M.D./Ph.D. Admissions Committee after extensive evaluation of prior scholarship and research experience, review of letters of recommendation, and in-depth interviews to assess motivation and determine the potential for success as physician-scientists. The program allows for flexibility in program affiliation, as well as the sequence and duration of clinical or research training, but most trainees pursue the following course of study. Students engage in laboratory research in the summer prior to the first year of Medical School. During the summer between the first and second year of Medical School, they carry out research in their proposed area of study. Following the second year of Medical School, each trainee begins his/her graduate training in advanced study. Trainees pursue dissertation research in a variety of outstanding graduate programs, including any of eight interdisciplinary training programs in the Emory Graduate School Division of Biological and Biomedical Sciences, in the Biomedical Engineering Program offered by the unique combined Department of Biomedical Engineering of Georgia Tech/Emory, in new programs in Biostatistics and Epidemiology offered by the Emory Rollins School of Public Health, or in one of several other scientific disciplines offered by the Graduate School of Arts and Sciences. Each trainee completes at least 14 months of clinical training after defending his/her thesis. The dramatic expansion of the research and clinical infrastructure at Emory and increased institutional support have facilitated the successful growth and development of the MSTP.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM008169-20
Application #
7099438
Study Section
National Institute of General Medical Sciences Initial Review Group (BRT)
Program Officer
Shapiro, Bert I
Project Start
1987-07-01
Project End
2007-06-30
Budget Start
2006-07-01
Budget End
2007-06-30
Support Year
20
Fiscal Year
2006
Total Cost
$819,104
Indirect Cost
Name
Emory University
Department
Neurology
Type
Schools of Medicine
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Bhutani, Srishti; Nachlas, Aline L Y; Brown, Milton E et al. (2018) Evaluation of Hydrogels Presenting Extracellular Matrix-Derived Adhesion Peptides and Encapsulating Cardiac Progenitor Cells for Cardiac Repair. ACS Biomater Sci Eng 4:200-210
Nawrocki, Kathryn L; Wetzel, Daniela; Jones, Joshua B et al. (2018) Ethanolamine is a valuable nutrient source that impacts Clostridium difficile pathogenesis. Environ Microbiol 20:1419-1435
Kersh, Anna E; Ng, Spencer; Chang, Yun Min et al. (2018) Targeted Therapies: Immunologic Effects and Potential Applications Outside of Cancer. J Clin Pharmacol 58:7-24
Galior, Kornelia; Ma, Victor Pui-Yan; Liu, Yang et al. (2018) Molecular Tension Probes to Investigate the Mechanopharmacology of Single Cells: A Step toward Personalized Mechanomedicine. Adv Healthc Mater 7:e1800069
Mener, Amanda; Arthur, Connie M; Patel, Seema R et al. (2018) Complement Component 3 Negatively Regulates Antibody Response by Modulation of Red Blood Cell Antigen. Front Immunol 9:676
Bongiorno, Tom; Gura, Jeremy; Talwar, Priyanka et al. (2018) Biophysical subsets of embryonic stem cells display distinct phenotypic and morphological signatures. PLoS One 13:e0192631
Hinrichs, Benjamin H; Matthews, Jason D; Siuda, Dorothée et al. (2018) Serum Amyloid A1 Is an Epithelial Prorestitutive Factor. Am J Pathol 188:937-949
Headen, Devon M; Woodward, Kyle B; Coronel, María M et al. (2018) Local immunomodulation with Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptance. Nat Mater 17:732-739
Petersen, Christopher T; Hassan, Mojibade; Morris, Anna B et al. (2018) Improving T-cell expansion and function for adoptive T-cell therapy using ex vivo treatment with PI3K? inhibitors and VIP antagonists. Blood Adv 2:210-223
Reinertsen, Erik; Clifford, Gari D (2018) A review of physiological and behavioral monitoring with digital sensors for neuropsychiatric illnesses. Physiol Meas 39:05TR01

Showing the most recent 10 out of 466 publications